Relapsing MS Treatment: Finding Support Videos (Sponsored)

Other search tools:Symptoms|Doctors|Medical Dictionary

Find us on:

WebMD Home

Relapsing MS Treatment: Know Your Options

Email a Friend

Print Article

This content is from our sponsor. The sponsor has sole editorial control.

Are you or someone you love dealing with Multiple Sclerosis? Do you have questions about the various support networks that are available for relapsing MS patients? Watch videos about different types of support that are available for you.

Indication

Rebif is used to treat relapsing forms of MS to decrease the frequency of relapses and delay the occurrence of some of the physical disability that is common in people with MS. Rebif is not approved for treatment of chronic progressive MS. Rebif is available in 22 mcg and 44 mcg prefilled, preassembled syringes and a titration pack.

Important safety information

Before beginning treatment, patients should discuss with their doctor the potential benefits and risks associated with Rebif. Let your doctor know if you have a history of depression, seizures, liver disease, thyroid problems, or blood cell count or bleeding problems, or if you have had previous allergic reactions to medications. Tell your doctor about all medicines you take, including prescription and non-prescription medicines, vitamins, and herbal supplements. Rebif and other medicines may affect each other causing serious side effects. Talk to your doctor before you take any new medicines. Rebif is not recommended for women who are or plan to become pregnant.

Potential serious side effects of Rebif include depression and risk of suicide, liver problems, risk to pregnancy, injection-site problems, and severe allergic reactions. Allergic reactions are rare and may be associated with difficulty in breathing and loss of consciousness, which require immediate medical attention.

The most common side effects with Rebif are injection-site reactions, flu-like symptoms (fever, chills, muscle aches, tiredness), depression, abdominal pain, elevated liver enzymes, and blood abnormalities.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

This information is not intended to replace discussions with your doctor. For additional information about Rebif, please consult the Medication Guide and talk to your doctor. You can also visit www.mslifelines.com or call toll-free 1-877-447-3243. Rebif is available by prescription only.

Rebif and MS LifeLines are registered trademarks of EMD Serono, Inc. or its affiliates.

Brought to you by EMD Serono, Inc. and Pfizer Inc, the co-marketers of
Rebif^® (interferon beta-1a) in the US.